{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T06:54:39Z","timestamp":1778914479507,"version":"3.51.4"},"reference-count":35,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["americanjournalofsurgery.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Surgery"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.amjsurg.2016.01.009","type":"journal-article","created":{"date-parts":[[2016,2,23]],"date-time":"2016-02-23T03:18:04Z","timestamp":1456197484000},"page":"886-893","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["HIV positivity and anal cancer outcomes: A single-center experience"],"prefix":"10.1016","volume":"211","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1029-1756","authenticated-orcid":false,"given":"Nicole","family":"Wieghard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyle D.","family":"Hart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine","family":"Kelley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kim C.","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel O.","family":"Herzig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timur","family":"Mitin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"Charles R.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vassiliki Liana","family":"Tsikitis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjsurg.2016.01.009_bib1","first-page":"9","article-title":"Cancer statistics, 2014","volume":"64","author":"Siegel","year":"2014","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.amjsurg.2016.01.009_bib2","first-page":"34","article-title":"HIV-positive anal cancer: an update for the clinician","volume":"1","author":"Dandapani","year":"2010","journal-title":"J\u00a0Gastrointest Oncol"},{"key":"10.1016\/j.amjsurg.2016.01.009_bib3","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/DCR.0b013e3182137de9","article-title":"Anal carcinoma in HIV-infected patients in the era of antiretroviral therapy: a comparative study","volume":"54","author":"Munoz-Bongrand","year":"2011","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.amjsurg.2016.01.009_bib4","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1086\/514194","article-title":"Prevalence and risk factors for human papillomavirus infection of the anal canal in human immunodeficiency virus (HIV)-positive and HIV-negative homosexual men","volume":"177","author":"Palefsky","year":"1998","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.amjsurg.2016.01.009_bib5","first-page":"169","article-title":"Anal cancer\u2014a review","volume":"6","author":"Salati","year":"2012","journal-title":"Int J Health Sci"},{"key":"10.1016\/j.amjsurg.2016.01.009_bib6","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1093\/jnci\/dji072","article-title":"Cancer risk in the Swiss HIV cohort study: associations with immunodeficiency, smoking and highly active antiretroviral therapy","volume":"97","author":"Clifford","year":"2005","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.amjsurg.2016.01.009_bib7","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1200\/JCO.2013.54.8644","article-title":"Cancer treatment disparities in HIV-infected individuals in the United States","volume":"32","author":"Suneja","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.amjsurg.2016.01.009_bib8","first-page":"129","article-title":"Anal cancer: current standards in care and recent changes in practice","volume":"65","author":"Shridhar","year":"2015","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.amjsurg.2016.01.009_bib9","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/sj.bjc.6605605","article-title":"Chemoradiation for the treatment of epidermoid anal cancer: 13-year follow-up of the first randomised UKCCCR Anal Cancer Trial (ACT I)","volume":"102","author":"Northover","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1016\/j.amjsurg.2016.01.009_bib10","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1200\/JCO.1997.15.5.2040","volume":"15","author":"Bartelink","year":"1997","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.amjsurg.2016.01.009_bib11","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1200\/JCO.1996.14.9.2527","article-title":"Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study","volume":"14","author":"Flam","year":"1996","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.amjsurg.2016.01.009_bib12","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1001\/jama.299.16.1914","article-title":"Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial","volume":"299","author":"Ajani","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.amjsurg.2016.01.009_bib13","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S1470-2045(13)70086-X","article-title":"Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2 \u00d7 2 factorial trial","volume":"14","author":"James","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.amjsurg.2016.01.009_bib14","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/annonc\/mdr050","article-title":"Chemoradiotherapy for anal cancer in HIV patients causes prolonged CD4 cell count suppression","volume":"23","author":"Alfa-Wali","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.amjsurg.2016.01.009_bib15","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1007\/BF02052589","article-title":"Squamous-cell carcinoma of the anus in HIV-positive patients","volume":"37","author":"Chadha","year":"1994","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.amjsurg.2016.01.009_bib16","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1007\/BF02234605","article-title":"HIV-positive patients with anal carcinoma have poorer treatment tolerance and outcome than HIV-negative patients","volume":"44","author":"Kim","year":"2001","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.amjsurg.2016.01.009_bib17","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0360-3016(98)00528-8","article-title":"The significance of pretreatment CD4 count on the outcome and treatment tolerance of HIV-positive patients with anal cancer","volume":"44","author":"Hoffman","year":"1999","journal-title":"Int J Radiat Onc Biol Phys"},{"key":"10.1016\/j.amjsurg.2016.01.009_bib18","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/DCR.0b013e31819eefa6","article-title":"HIV and anal cancer outcomes: a single institution's experience","volume":"52","author":"Hogg","year":"2009","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.amjsurg.2016.01.009_bib19","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1007\/s10350-004-0584-1","article-title":"Outcome of HIV-infected patients with invasive squamous-cell carcinoma of the anal canal in the era of highly active antiretroviral therapy","volume":"47","author":"Stadler","year":"2004","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.amjsurg.2016.01.009_bib20","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1200\/JCO.2007.15.2348","article-title":"HIV-specific differences in outcome of squamous cell carcinoma of the anal canal: a multicentric cohort study of HIV-positive patients receiving highly active antiretroviral therapy","volume":"26","author":"Oehler-Janne","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.amjsurg.2016.01.009_bib21","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s10350-007-9154-7","article-title":"Invasive anal squamous-cell carcinoma in the HIV-positive patient: outcome in the era of highly active antiretroviral therapy","volume":"51","author":"Wexler","year":"2008","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.amjsurg.2016.01.009_bib22","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ijrobp.2008.10.046","article-title":"Outcomes of chemoradiotherapy with 5-Fluorouracil and mitomycin C for anal cancer in immunocompetent versus immunodeficient patients","volume":"75","author":"Seo","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.amjsurg.2016.01.009_bib23","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/j.ijrobp.2009.03.060","article-title":"Concurrent chemoradiotherapy with 5-fluorouracil and mitomycin C for invasive anal carcinoma in human immunodeficiency virus-positive patients receiving highly active antiretroviral therapy","volume":"76","author":"Fraunholz","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.amjsurg.2016.01.009_bib24","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1001\/archsurg.136.8.886","article-title":"The evolving treatment of anal cancer: how are we doing?","volume":"136","author":"Whiteford","year":"2001","journal-title":"Arch Surg"},{"key":"10.1016\/j.amjsurg.2016.01.009_bib25","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1097\/DCR.0b013e318255815e","article-title":"Practice parameters for anal squamous neoplasms","volume":"55","author":"Steele","year":"2012","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.amjsurg.2016.01.009_bib26","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/COC.0000000000000009","article-title":"Intensity-modulated radiation therapy for anal cancer: results from a multi-institutional retrospective cohort study","volume":"39","author":"Call","year":"2016","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.amjsurg.2016.01.009_bib27","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ijrobp.2013.01.034","article-title":"RTOG 0529: intensity modulated radiation therapy and anal cancer, a step in the right direction?","volume":"86","author":"Herman","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.amjsurg.2016.01.009_bib28","doi-asserted-by":"crossref","first-page":"4344","DOI":"10.1200\/JCO.2012.43.8085","article-title":"Long-term update of US GI intergroup RTOG 98-11 phase III trial for anal carcinoma: survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil\/mitomycin versus fluorouracil\/cisplatin","volume":"30","author":"Gunderson","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.amjsurg.2016.01.009_bib29","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1097\/QAD.0b013e3281c61201","article-title":"Anal squamous intraepithelial lesions and condyloma in HIV-infected heterosexual men, homosexual men and women: prevalence and associated factors","volume":"21","author":"Abramowitz","year":"2007","journal-title":"AIDS"},{"key":"10.1016\/j.amjsurg.2016.01.009_bib30","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1086\/505219","article-title":"Screening HIV-infected individuals for anal cancer precursor lesions: a systematic review","volume":"43","author":"Chiao","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.amjsurg.2016.01.009_bib31","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/DCR.0000000000000057","article-title":"Long-term effects of chemoradiotherapy for anal cancer in patients with HIV infection: oncological outcomes, immunological status, and the clinical course of the HIV disease","volume":"57","author":"Fraunholz","year":"2014","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.amjsurg.2016.01.009_bib32","unstructured":"Clinical Trials.gov. Cisplatin, FluorourAcil, Cetuximab, and Radiation Therapy in Treating Patients with HIV Stage I, Stage II, or Stage III Anal Cancer. Available at: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00324415. Accessed April 30, 2015."},{"key":"10.1016\/j.amjsurg.2016.01.009_bib33","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1007\/s10350-004-0910-7","article-title":"Anal carcinomas in HIV-positive patients: high-dose chemoradiotherapy is feasible in the era of highly active antiretroviral therapy","volume":"48","author":"Blazy","year":"2005","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.amjsurg.2016.01.009_bib34","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1093\/annonc\/mdu188","article-title":"Tumour- and treatment-related colostomy rates following mitomycin C or cisplatin chemoradiation with or without maintenance chemotherapy in squamous cell carcinoma of the anus in the ACT II trial","volume":"25","author":"Glynne-Jones","year":"2014","journal-title":"Ann Oncol"},{"key":"10.1016\/j.amjsurg.2016.01.009_bib35","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/DCR.0000000000000476","article-title":"HIV infection is associated with poor outcomes for patients with anal Cancer in the highly active antiretroviral therapy era","volume":"58","author":"Grew","year":"2015","journal-title":"Dis Colon Rectum"}],"container-title":["The American Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002961016300587?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002961016300587?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T18:07:26Z","timestamp":1757700446000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002961016300587"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["S0002961016300587"],"URL":"https:\/\/doi.org\/10.1016\/j.amjsurg.2016.01.009","relation":{},"ISSN":["0002-9610"],"issn-type":[{"value":"0002-9610","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HIV positivity and anal cancer outcomes: A single-center experience","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjsurg.2016.01.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}